person

Luca P.

Country
Italy
Department
Gastroenterology and liver unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
87
Sites with multiple studies

Has run more than one trial at 87 of 277 partner sites.

Specializations

Inflammatory Bowel Disease Research

This investigator specializes in treating complex gastrointestinal conditions, with particular emphasis on inflammatory bowel diseases (IBD). Their research encompasses both Crohn's disease and ulcerative colitis, focusing on innovative therapeutic approaches.

  • Moderate to Severe Crohn's Disease Management
  • Advanced Ulcerative Colitis Treatments
  • Novel Biological Therapies

Their expertise extends to evaluating new therapeutic agents and biosimilar medications for inflammatory bowel conditions.

Therapeutic Innovation

The investigator's work involves evaluating novel biological agents and their applications in gastrointestinal disorders. They conduct research on emerging treatments including subcutaneous therapeutics and targeted biological medications.

  • Biosimilar Development
  • Comparative Treatment Studies
  • Advanced Therapeutic Applications

Their research includes assessment of treatment efficacy and safety profiles in gastrointestinal conditions.

Clinical Advancement

Focusing on moderate to severe gastrointestinal conditions, the investigator evaluates treatment responses and clinical outcomes. Their work encompasses both monotherapy and combination therapy approaches.

  • Treatment Response Assessment
  • Clinical Remission Studies
  • Therapeutic Equivalence Evaluation

The research includes investigation of treatment efficacy in achieving clinical remission for inflammatory bowel conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.